The Benefit of Hemodialysis Plus Hemoperfusion on Mortality

NCT03227770 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1362

Enrollment

OTHER

Sponsor class

Conditions

End-stage Renal Disease

Interventions

DEVICE: hemoperfusion combined with hemodialysis
DEVICE: hemodialysis

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]